BioLife Solutions, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
BioLife Solutions, Inc. (BLFS) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$5.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$755.00K, a 187.38% decline year-over-year.
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$4.40M.
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $680.00K, a 90.37% decline year-over-year.
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.56M, a 487.97% increase year-over-year.
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$1.14M, a 117.64% decline from fiscal 2024.
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $6.49M, a 223.93% increase from fiscal 2023.
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.00M, a 12.03% increase from fiscal 2022.
- BioLife Solutions, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $1.79M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$755.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$5.16M 10-Q · filed 2026-08-06 | -$4.47M derived: sum of 3 quarters · filed 2026-08-06 | -$2.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$4.40M 10-Q · filed 2026-05-07 | -$3.72M derived: sum of 2 quarters · filed 2026-05-07 | -$2.16M derived: sum of 3 quarters · filed 2026-05-07 | -$1.29M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $680.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.24M derived: sum of 2 quarters · filed 2026-02-26 | $3.11M derived: sum of 3 quarters · filed 2026-08-06 | -$1.14M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.43M derived: sum of 2 quarters · filed 2026-08-06 | -$1.82M 10-Q · filed 2025-11-06 | $5.24M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.39M 10-Q · filed 2026-08-06 | $3.67M derived: sum of 3 quarters · filed 2026-08-06 | $3.94M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$4.25M 10-Q · filed 2026-05-07 | $2.81M derived: sum of 2 quarters · filed 2026-05-07 | $3.07M derived: sum of 3 quarters · filed 2026-05-07 | $5.06M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.33M derived: sum of 2 quarters · filed 2026-02-26 | $9.31M derived: sum of 3 quarters · filed 2026-02-26 | $6.49M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.25M derived: sum of 2 quarters · filed 2025-11-06 | -$574.00K 10-Q · filed 2025-11-06 | -$96.00K 10-Q · filed 2024-11-12 | $3.12M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$840.00K 10-Q · filed 2025-08-07 | -$358.00K 10-Q · filed 2024-08-09 | $2.85M derived: sum of 3 quarters · filed 2026-02-26 | $1.05M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$2.83M 10-Q · filed 2025-05-08 | -$2.77M 10-Q · filed 2024-05-10 | $869.00K derived: sum of 2 quarters · filed 2026-02-26 | -$933.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.19M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.89M derived: sum of 2 quarters · filed 2026-02-26 | $1.63M derived: sum of 3 quarters · filed 2026-02-26 | $2.00M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.06M derived: sum of 2 quarters · filed 2024-11-12 | -$1.69M 10-Q · filed 2024-11-12 | -$349.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | -$261.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $110.00K 10-Q · filed 2024-08-09 | $1.45M derived: sum of 3 quarters · filed 2025-03-03 | $2.93M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $371.00K 10-Q · filed 2024-05-10 | $1.71M derived: sum of 2 quarters · filed 2025-03-03 | $3.19M derived: sum of 3 quarters · filed 2025-03-03 | $3.23M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.82M derived: sum of 2 quarters · filed 2025-03-03 | $2.86M derived: sum of 3 quarters · filed 2025-03-03 | $1.79M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.52M derived: sum of 2 quarters · filed 2023-11-09 | $444.00K 10-Q · filed 2023-11-09 | -$962.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.03M 10-Q · filed 2023-08-09 | -$2.44M derived: sum of 3 quarters · filed 2024-02-29 | -$4.29M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$1.07M 10-Q · filed 2023-05-11 | -$2.48M derived: sum of 2 quarters · filed 2024-02-29 | -$4.33M derived: sum of 3 quarters · filed 2024-02-29 | -$6.70M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$3.25M derived: sum of 2 quarters · filed 2024-02-29 | -$5.63M derived: sum of 3 quarters · filed 2024-02-29 | -$3.94M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$4.22M derived: sum of 2 quarters · filed 2022-11-09 | -$2.53M 10-Q · filed 2022-11-09 | -$2.44M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-06-30 | -$2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$681.00K 10-Q · filed 2022-08-09 | -$3.88M 10-Q · filed 2021-08-16 | -$590.00K derived: sum of 3 quarters · filed 2023-03-31 | -$78.00K derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2021-03-31 | $1.69M 10-Q · filed 2022-05-10 | $1.78M derived: sum of 2 quarters · filed 2023-03-31 | $2.29M derived: sum of 3 quarters · filed 2023-03-31 | $2.17M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2020-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $603.00K derived: sum of 2 quarters · filed 2023-03-31 | $476.00K derived: sum of 3 quarters · filed 2023-03-31 | $780.00K 10-K · filed 2023-03-31 | ||||
| 2020-09-30 | $512.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $385.00K derived: sum of 2 quarters · filed 2021-11-15 | $689.00K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $177.00K 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | $304.00K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | -$327.00K 10-K · filed 2022-03-31 | -$246.00K 10-K · filed 2020-05-15 | ||||||
| 2018-12-31 | $497.00K 10-K · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |